FRANK E. THOMAS - 15 Sep 2022 Form 4 Insider Report for Spero Therapeutics, Inc. (SPRO)

Role
Director
Signature
/s/ Tamara Joseph, Attorney-in-Fact for Frank E. Thomas
Issuer symbol
SPRO
Transactions as of
15 Sep 2022
Net transactions value
$0
Form type
4
Filing time
19 Sep 2022, 17:40:47 UTC
Previous filing
03 Jun 2022
Next filing
06 Oct 2022
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction SPRO Common Stock Award $0 +15,000 $0.000000 15,000 15 Sep 2022 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Consists of restricted stock units ("RSUs"). Each RSU represents the right to receive one share of common stock upon vesting. The RSUs vest on September 15, 2023, subject to the Reporting Person's continued service through the applicable vesting date.